Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2011 1
2012 5
2013 2
2014 1
2015 6
2016 7
2017 3
2018 1
2019 2
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
O'Toole SA, Huang Y, Norris L, Power Foley M, Shireen R, McDonald S, Kamran W, Ibrahim N, Ward M, Thompson C, Murphy C, D'Arcy T, Farah N, Heron E, O'Leary JJ, Abu Saadeh F, Gleeson N. O'Toole SA, et al. Gynecol Oncol. 2021 Feb;160(2):514-519. doi: 10.1016/j.ygyno.2020.11.004. Epub 2020 Nov 16. Gynecol Oncol. 2021. PMID: 33213897 Free article.
Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
Plotti F, Capriglione S, Terranova C, Montera R, Aloisi A, Damiani P, Muzii L, Scaletta G, Benedetti-Panici P, Angioli R. Plotti F, et al. Tumour Biol. 2012 Dec;33(6):2117-23. doi: 10.1007/s13277-012-0471-7. Epub 2012 Aug 9. Tumour Biol. 2012. PMID: 22875782
Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.
Dobrzycka B, Mackowiak-Matejczyk B, Terlikowska KM, Kinalski M, Terlikowski SJ. Dobrzycka B, et al. Adv Med Sci. 2016 Mar;61(1):23-7. doi: 10.1016/j.advms.2015.07.010. Epub 2015 Aug 9. Adv Med Sci. 2016. PMID: 26344910
PURPOSE: The aim of the study was to establish whether preoperative serum levels of HE4 and CA125 could be a good predictor for lymphadenectomy in the early stage of endometrioid adenocarcinoma of the uterus. MATERIAL AND METHODS: Preoperative serum HE4 and CA125 were meas …
PURPOSE: The aim of the study was to establish whether preoperative serum levels of HE4 and CA125 could be a good predictor for lymphadenect …
Human epididymis protein 4 (HE4) in benign and malignant diseases.
Hertlein L, Stieber P, Kirschenhofer A, Krocker K, Nagel D, Lenhard M, Burges A. Hertlein L, et al. Clin Chem Lab Med. 2012 Dec;50(12):2181-8. doi: 10.1515/cclm-2012-0097. Clin Chem Lab Med. 2012. PMID: 23093276
The area under the curve(AUC) of HE4 in women was highest in ovarian cancer and borderline tumors as compared to benign gynecological disorders(88.9 % ), with a sensitivity of 67.4 % at 95 % specificity.Also, significantly elevated concentrations of HE4 with reference to the resp …
The area under the curve(AUC) of HE4 in women was highest in ovarian cancer and borderline tumors as compared to benign gynecological disord …
Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
Knific T, Osredkar J, Smrkolj Š, Tonin I, Vouk K, Blejec A, Frković Grazio S, Rižner TL. Knific T, et al. Gynecol Oncol. 2017 Oct;147(1):126-132. doi: 10.1016/j.ygyno.2017.07.130. Epub 2017 Jul 21. Gynecol Oncol. 2017. PMID: 28735628
METHODS: Prospective case-control study of 133 women who underwent surgical treatment at the University Medical Centre Ljubljana (64 patients with endometrial cancer, 69 control patients with prolapsed uterus or myoma). Serum CA-125 and HE4 levels were determined using ele …
METHODS: Prospective case-control study of 133 women who underwent surgical treatment at the University Medical Centre Ljubljana (64 patient …
Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor Site.
Celik B, Bulut T, Yalcin AD. Celik B, et al. Pathol Oncol Res. 2020 Apr;26(2):1145-1151. doi: 10.1007/s12253-019-00675-4. Epub 2019 Jun 5. Pathol Oncol Res. 2020. PMID: 31165997 Free article.
CA125 and p53 are reliable markers that are useful for differentiating both uterine serous and ovarian serous carcinoma from their most common subtypes (endometrioid type carcinoma of ovary and uterus) but so far there is no histopathologic marker that differentiates USC f …
CA125 and p53 are reliable markers that are useful for differentiating both uterine serous and ovarian serous carcinoma from their most comm …
25 results